Correlation Between Talanx AG and ChemoMetec A/S

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Talanx AG and ChemoMetec A/S at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Talanx AG and ChemoMetec A/S into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Talanx AG and ChemoMetec AS, you can compare the effects of market volatilities on Talanx AG and ChemoMetec A/S and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Talanx AG with a short position of ChemoMetec A/S. Check out your portfolio center. Please also check ongoing floating volatility patterns of Talanx AG and ChemoMetec A/S.

Diversification Opportunities for Talanx AG and ChemoMetec A/S

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between Talanx and ChemoMetec is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Talanx AG and ChemoMetec AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ChemoMetec A/S and Talanx AG is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Talanx AG are associated (or correlated) with ChemoMetec A/S. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ChemoMetec A/S has no effect on the direction of Talanx AG i.e., Talanx AG and ChemoMetec A/S go up and down completely randomly.

Pair Corralation between Talanx AG and ChemoMetec A/S

Assuming the 90 days horizon Talanx AG is expected to generate 0.49 times more return on investment than ChemoMetec A/S. However, Talanx AG is 2.02 times less risky than ChemoMetec A/S. It trades about 0.22 of its potential returns per unit of risk. ChemoMetec AS is currently generating about 0.07 per unit of risk. If you would invest  8,080  in Talanx AG on December 22, 2024 and sell it today you would earn a total of  1,510  from holding Talanx AG or generate 18.69% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Talanx AG  vs.  ChemoMetec AS

 Performance 
       Timeline  
Talanx AG 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Talanx AG are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Talanx AG reported solid returns over the last few months and may actually be approaching a breakup point.
ChemoMetec A/S 

Risk-Adjusted Performance

Modest

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ChemoMetec AS are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ChemoMetec A/S may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Talanx AG and ChemoMetec A/S Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Talanx AG and ChemoMetec A/S

The main advantage of trading using opposite Talanx AG and ChemoMetec A/S positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Talanx AG position performs unexpectedly, ChemoMetec A/S can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ChemoMetec A/S will offset losses from the drop in ChemoMetec A/S's long position.
The idea behind Talanx AG and ChemoMetec AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk